New pathway to cheap insulin — Researchers from Helmholtz Centre in Braunschweig, Germany, publish new and more efficient method to manufacture insulin – More than eight million diabetics live in Germany. Diabetes is not restricted to our prosperous society and the highest growth rates often occur in countries with aspiring economies such as in Asia.
Mount Sinai researchers move closer to a universal influenza vaccine – Researchers at Mount Sinai School of Medicine have developed a new influenza vaccine that brings science one step closer to a universal influenza vaccine that would eliminate the need for seasonal flu shots.
MSU researchers testing vaccine to help people quit smoking — Novel approach blocks ‘pleasure sensation’ – In a unique twist to a decades-old health crisis, Michigan State University researchers are testing a new vaccine to help people quit smoking and avoid relapses.
Discovery of how BanLec binds to key HIV-1 protein opens door to developing microcides that can prevent sexual transmission of HIV
– A potent new inhibitor of HIV, derived from bananas, may open the door to new treatments to prevent sexual transmission of HIV, according to a University of Michigan Medical School study published this week.
Federal Vaccine Court Rules Against Autism Families — Government’s Refusal to Fund Sound Science Stacks Deck Against Vaccine-Injured Children and Casts Doubt on the Integrity of the National Immunization Program says SafeMinds. – US ‘vaccine court’ ruled in three separate cases that the mercury containing preservative thiomersal does not cause autism. This ruling supports the broad scientific consensus.
Pneumococcal vaccine offers protection to HIV-infected African adults in clinical trial – A clinical trial of a vaccine against a major cause of pneumonia and meningitis has shown that it can prevent three out of four cases of re-infection in HIV-infected adults in Africa.
New data on rotavirus vaccine from Mexico and Africa show lifesaving impact in the developing world — Evidence informed WHO recommendation that all countries introduce rotavirus vaccine – Rotavirus is the leading cause of severe, acute gastroenteritis among infants and young children throughout the world and is responsible for an estimated 527,000 deaths among children under five each year.
Promising candidates for malaria vaccine revealed – Walter and Eliza Hall Institute researchers have uncovered a group of proteins that could form the basis of an effective vaccine against malaria.
It is not too late for those who have not been immunized against the novel H1N1 influenza A virus or seasonal influenza to protect themselves from a potentially serious and possibly fatal illness. – It is not too late for those who have not been immunized against the novel H1N1 influenza A virus or seasonal influenza to protect themselves from a potentially serious and possibly fatal illness.
Johns Hopkins researchers say vaccine appears to ‘mop up’ leukemia cells Gleevec leaves behind — Team cautions that results are very preliminary and they cannot yet rule out other reasons for success – Johns Hopkins Kimmel Cancer Center researchers say preliminary studies show that a vaccine made with leukemia cells may be able to reduce or eliminate the last remaining cancer cells in some chronic myeloid leukemia (CML) patients taking the drug Imatinib mesylate (Gleevec).
Insect cells provide the key to alternative swine flu vaccination — New production method can meet the demand of a global flu pandemic – Scientists in Vienna have developed a new technique for producing vaccines for H1N1, ‘swine flu’, based on insect cells. The research, published today in the Biotechnology Journal, reveals how influenza vaccines can be produced faster than through the traditional method of egg-based production, revealing a new strategy for the fight against influenza pandemics.
H1N1 Vaccination Clinics Open to All at Oklahoma City-County Health Department – The Oklahoma City-County Health Department (OCCHD) is offering extended hours and days for both H1N1 and seasonal flu vaccinations at the main building at 921 NE 23rd Street in Oklahoma City.
